Aripiprazle in ADHD and ODD

Phase 3

Recruiting

Conditions: Condition 1: Attention deficit/hyperactivity disorder. Condition 2: oppositional Defiant Disorder.
Attention-deficit hyperactivity disorders
F.91.3

Registration Number: IRCT20160530028182N5

Lead Sponsor: Sanandaj University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

Age between 6 -12 years
Diagnosis of ADHD and ODD based on DSM5
without effective medication taking on mental status at least 2 weeks before the study

Exclusion Criteria

Intelectual disability based on clinical suspicious
presence of uncontroled siezure
Drug side effects and hypersensivity
Recieving of any other drugs
History of psychological disorder except for ADHD and ODD
presence of medical deasese such as cardiac deaseses

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvment in Attention-deficit symptoms. Timepoint: Baselin , second,fourth and eighth weeks after intervention. Method of measurement: Canner's and ADHD Rating scales.;Improvment in Impulsivity symptoms. Timepoint: Baselin , second,fourth and eighth weeks after intervention. Method of measurement: Canner's and ADHD Rating scales.;Improvment in hyperactivation symptoms. Timepoint: Baselin , second,fourth and eighth weeks after intervention. Method of measurement: Canner's and ADHD Rating scales.;Improvment in behavioral symptoms. Timepoint: Baselin , second,fourth and eighth weeks after intervention. Method of measurement: Canner's and ADHD Rating scales.

Secondary Outcome Measures

Name	Time	Method
Severity of ADHD symptoms. Timepoint: Baselin , second ,fourth and eighth weeks after intervention. Method of measurement: ADHD Rating scale and CGI.;?Drug Sideeffects. Timepoint: Baselin , second ,fourth and eighth weeks after intervention. Method of measurement: Sideeffects quessionners.